Terry Jo Bichell worked as a documentary filmmaker in the early days of videotape, then became a public health nurse-midwife after filming a difficult birth in West Africa. When her youngest child, Lou, was diagnosed with Angelman syndrome, she switched from midwifery to clinical research on Angelman syndrome. Eventually, she went back to school to earn a PhD in neuroscience from Vanderbilt University in an effort to find treatments for her son. Along the way, she studied gene-environment interactions in Huntington disease as well as circadian aspects of Angelman syndrome and was a columnist for HDBuzz. After graduating, she was the Founding Director of the Angelman Biomarkers and Outcome Measures Alliance until 2018. Dr. Bichell founded a new non-profit in 2019, COMBINEDBrain (Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders), to assist other rare and ultra-rare neurogenetic disorders with clinical trial preparations.

You may also like

78 - Therapeutic Strategies for Autism: Targeting Three Levels of the Central Dogma of Molecular Biology - Presented to the SYNGAP1 Community

Prof. Lilia Iakoucheva, Ph.D. & Mr. Derek Hong, M.S.

UCSD School of Medicine

76 - Involvement of the brain endothelium in neurodevelopmental disorders like SYNGAP1

Baptiste Lacoste, PhD

The University of Ottawa

79 - Quantifying perturbed SynGAP1 function caused by coding mutations

Michael Courtney, PhD

Turku Bioscience Centre, Finland